CLINICAL STUDIES
Prevalence and correlates of aortic regurgitation in american indians: the Strong Heart Study
Nathaniel E. Lebowitz, MDa,
Jonathan N. Bella, MDa,
Mary J. Roman, MD, FACCa,
Jennifer E. Liu, MDa,
Dawn P. Fishman, BAa,
Mary Paranicas, BAa,
Elisa T. Lee, PhD*,
Richard R. Fabsitz, MA, MPH ,
Thomas K. Welty, MD ,
Barbara V. Howard, PhD and
Richard B. Devereux, MD, FACCa
a Department of Medicine, The New York Hospital–Cornell Medical Center, New York, New York, USA
* School of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
National Heart Lung and Blood Institute, Bethesda, Maryland, USA
Aberdeen Area Tribal Chairman’s Health Board, Rapid City, South Dakota, USA
Medlantic Research Institute, Washington, DC, USA
Manuscript received December 9, 1998;
revised manuscript received January 28, 2000,
accepted March 30, 2000.
Reprint requests and correspondence: Dr. Richard B. Devereux, Division of Cardiology, Box 222, The New York Presbyterian Hospital–Weill Cornell Medical Center, 525 East 68th Street, New York, New York 10021
rbdevere{at}med.cornell.edu
OBJECTIVES
We sought to determine the prevalence and correlates of aortic regurgitation (AR) in a population-based sample group.
BACKGROUND
Concern over induction of AR by weight loss medication highlights the importance of assessing the prevalence and correlates of AR in unselected patient groups.
METHODS
Aortic regurgitation was assessed by color flow Doppler echocardiography in 3,501 American Indian participants age 47 to 81 years during the second Strong Heart Study.
RESULTS
Mild (1+) AR was present in 7.3%, 2+ AR in 2.4% and 3+ to 4+ AR in 0.3% of participants, more frequently in those  60 years old than in those <60 years old (14.4% vs. 5.8%, p < 0.001); AR was unrelated to gender. Compared with participants without AR, those with mild AR had a lower body mass index (p < 0.004) and higher systolic pressure (p < 0.003). Participants with AR had larger aortic root diameters (3.6 ± 0.4 vs. 3.4 ± 0.4 cm, p < 0.001), higher creatinine levels (1.3 ± 1.3 vs. 1.0 ± 1.0 mg/dl, p < 0.001) and higher urine albumin/creatinine levels (3.6 ± 2.3 vs. 3.3 ± 2.0 log, p < 0.001), as well as higher prevalences of aortic stenosis (AS) or mitral stenosis (MS) (p < 0.001). Regression analysis showed that AR was independently related to older age and larger aortic roots (p < 0.0001), AS and absence of diabetes (p = 0.002), MS (p = 0.003) and higher log urine albumin/creatinine (p = 0.005).
CONCLUSIONS
Aortic regurgitation occurred in 10% of a sample group of middle-aged to older adults and was related to older age, larger aortic root diameter, aortic and mitral stenosis and albuminuria. There was no association of AR with being overweight and a negative association of AR with diabetes.
|
Abbreviations and Acronyms
| | AR | = aortic regurgitation | | AS | = aortic stenosis | | ASE | = American Society of Echocardiography | | ECG | = electrocardiographic | | JNC-V | = Fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure | | LV | = left ventricle | | MS | = mitral stenosis | | SHS | = Strong Heart Study |
|
This article has been cited by other articles:
|
|
|
|
 
S. Champetier, A. Bojmehrani, J. Beaudoin, D. Lachance, E. Plante, E. Roussel, J. Couet, and M. Arsenault
Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the {beta}-adrenergic and renin-angiotensin systems
Am J Physiol Heart Circ Physiol,
March 1, 2009;
296(3):
H669 - H677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Gerdts, D. Cramariuc, G. de Simone, K. Wachtell, B. Dahlof, and R. B. Devereux
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)
Eur J Echocardiogr,
November 1, 2008;
9(6):
809 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Gerdts, P. M. Okin, G. de Simone, D. Cramariuc, K. Wachtell, K. Boman, and R. B. Devereux
Gender Differences in Left Ventricular Structure and Function During Antihypertensive Treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study
Hypertension,
April 1, 2008;
51(4):
1109 - 1114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Enriquez-Sarano and A. J. Tajik
Aortic Regurgitation
N. Engl. J. Med.,
October 7, 2004;
351(15):
1539 - 1546.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Bella, J. W. MacCluer, M. J. Roman, L. Almasy, K. E. North, T. K. Welty, E. T. Lee, R. R. Fabsitz, B. V. Howard, and R. B. Devereux
Genetic Influences on Aortic Root Size in American Indians: The Strong Heart Study
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2002;
22(6):
1008 - 1011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Gardin, N. J. Weissman, C. Leung, J. A. Panza, D. Fernicola, K. D. Davis, G. D. Constantine, and C. L. Reid
Clinical and Echocardiographic Follow-up of Patients Previously Treated With Dexfenfluramine or Phentermine/Fenfluramine
JAMA,
October 24, 2001;
286(16):
2011 - 2014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Palmieri, J. N. Bella, D. K. Arnett, M. J. Roman, A. Oberman, D. W. Kitzman, P. N. Hopkins, M. Paranicas, D. C. Rao, and R. B. Devereux
Aortic Root Dilatation at Sinuses of Valsalva and Aortic Regurgitation in Hypertensive and Normotensive Subjects : The Hypertension Genetic Epidemiology Network Study
Hypertension,
May 1, 2001;
37(5):
1229 - 1235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Collis, R. B. Devereux, M. J. Roman, G. de Simone, J.-L. Yeh, B. V. Howard, R. R. Fabsitz, and T. K. Welty
Relations of Stroke Volume and Cardiac Output to Body Composition : The Strong Heart Study
Circulation,
February 13, 2001;
103(6):
820 - 825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
